Illinois State Representative Theresa Mah (D) introduced House Bill 2992 today, known as the Healing Opportunities through Psilocybin Equity Pilot Program Act.
The legislation would create a regulatory framework for the production, distribution, and supervised use of psilocybin, the psychoactive compound found in psychedelic mushrooms.
The bill outlines the formation of the Illinois Psilocybin Advisory Board within the Department of Financial and Professional Regulation. The board would be responsible for guiding the development of regulations and overseeing the program’s implementation. Multiple state agencies—including the Department of Public Health, the Department of Agriculture, the Illinois State Police, and the Department of Revenue—would play roles in regulating different aspects of the psilocybin industry.
A program development period would precede the licensing process, ensuring regulatory measures are in place before commercial activities begin. By July 1 of the third year after the bill’s effective date, Illinois would begin issuing various licenses for psilocybin-related businesses. Licensees and their representatives would be granted immunity from certain criminal and civil penalties related to the manufacture, delivery, and possession of psilocybin products, provided they comply with the law.
HB 2992 also proposes a 15% tax on psilocybin purchases, with revenue directed to newly established state funds. Additionally, the bill includes provisions for the discipline of licensees, administrative hearings, and penalties for violations. It also amends the Illinois Freedom of Information Act to exempt certain psilocybin-related data from public disclosure and modifies the state’s DUI laws to account for psilocybin use.
If enacted, the bill would take effect immediately, setting Illinois on a path toward a regulated psilocybin program. The full text of HB 2992 is available here.
